Trial Profile
Non-interventional Study on the Use of Mircera in the Treatment of Chronic Renal Anemia in Patients With Chronic Kidney Disease Stages III-IV Not on Dialysis and in Patients on Stage V on Hemodialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2015
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Roche
- 01 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 11 May 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Apr 2015 to 1 May 2015.
- 11 May 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Apr 2015 to 1 May 2015.